Top 10 Indian origin, BA/BE CROs to look upon in 2022 Kumar Jeetendra | April 2, 2022 The key to making profits in the generic drug market is reaching the market as early as possible by getting proper regulatory approval. Generic medicines play an essential role in the pharmaceutical market because of their lower cost than branded drug molecules. Manufacturers of Generic Pharmaceuticals need not begin from scratch and carry out R&D, …
Hester Biosciences Limited, India’s 2nd Largest Poultry Vaccine Manufacturer, ventures into the Pet Care Industry Kumar Jeetendra | March 23, 2022 22 March 2022: Hester Biosciences Limited is all set to expand into the rapidly growing Pet Care sector this April. India has the fastest-growing pet care market worldwide, with it growing by 14% in 2022, making this an exciting and valuable opportunity for the poultry vaccine giant. Hester’s comprehensive knowledge of animal biology, cutting-edge R&D …
Molecular Health and collaborators prove new analytical approach that leverages real-world data to anticipate molecular causation of adverse drug reactions Kumar Jeetendra | March 10, 2022 Molecular Health and collaborators at the University of Florida College of Pharmacy, Takeda Oncology, and thinkQ² published a triad of articles that describe and prove the concept of a novel systems approach to elucidate molecular mechanisms of drug toxicities using real-world data (RWD). “We have established an approach that transforms real-world, in-human treatment outcomes and …
Arctoris and Evariste Technologies form a Joint Venture to Identify Novel Small Molecule cMET Inhibitors for Non-Small Cell Lung Cancer Kumar Jeetendra | March 7, 2022 07 March 2022, Oxford and London – Life Science Newswire – Arctoris, a tech-enabled biopharma company, and Evariste Technologies, an AI-drug discovery company, today announced they have formed a joint venture to identify novel small molecule kinase inhibitors for treatment of patients with Non-Small Cell Lung Cancer (NSCLC). Current treatment options for NSCLC are limited, …
Medix Biochemica announces the launch of its refreshed, and expanding, brand Kumar Jeetendra | March 3, 2022 Espoo, Finland – 3 March 2022 – Life Science Newswire – Medix Biochemica is committed to offering its customers the most comprehensive IVD raw materials portfolio in the business. To do this, Medix Biochemica has acquired several companies, each with their own expertise across the IVD market. In 2019, Lee Biosolutions was acquired, followed by …
OxygenForIndia Announces New Partners – Swasth Alliance and Indiaspora Kumar Jeetendra | February 21, 2022 21st February 2022 – OxygenForIndia (OFI), a volunteer-run campaign to deliver medical oxygen in response to the COVID-19 second wave in India, recently welcomed on board new partners – Swasth Alliance and Indiaspora to assist in its effort to form a National Oxygen Grid. The OxygenForIndia initiative was launched in the wake of the unprecedented …
VitaDAO and Molecule AG partner with Apollo Health Ventures to build the longevity biotech & Web3 ecosystem Kumar Jeetendra | February 21, 2022 Feb. 21, 2022, Switzerland – Life Science Newswire – Molecule, a biotech IP Web3 marketplace, announces a tripartite partnership with Apollo Health Ventures, a leading longevity-focused venture capital fund, and VitaDAO, a decentralized autonomous organization funding early-stage longevity biotech (“LongBio”) R&D. VitaDAO and Molecule collaboratively source geroscience assets and finance R&D at universities, institutes, and …
Inhalation Sciences signs IRS contract worth 584,000 SEK with leading nanotech company Kumar Jeetendra | February 18, 2022 Inhalation Research Services, ISAB’s contract research organization, has signed a contract worth 584 000 SEK with a leading nanotechnology company that specializes in developing new inhalable nanoporous particles for drug delivery. The client has chosen ISAB’s unique intratracheal in vivo exposure module for its research project, due to its proven precision and reliability. The development …
TPG-Backed Asia Healthcare Holdings Raises $170 Million from Singapore’s GIC Kumar Jeetendra | February 14, 2022 India: February 14, 2022 – Asia Healthcare Holdings (“AHH”), the single specialty healthcare delivery platform backed by TPG Growth, has signed definitive documentation for a $170 million investment from Singapore’s sovereign wealth fund GIC (“GIC”). The investment is one of the largest in the single specialty healthcare services sector in India. Incubated by TPG Growth …
Germfree Launches Novel Mobile Cleanroom Technology for Advanced Therapies Kumar Jeetendra | February 3, 2022 Miami Beach, Florida, US – February 02, 2022 – Life Science Newswire – A first of its kind, mobile platform for cell and gene therapy was introduced by Germfree Labs, a Florida company, at Advanced Therapies Week in Miami Beach. The new bioGO® cGMP Mobile Cleanroom solves complex logistical challenges facing the CGT (cell and …
Medix Biochemica expands its molecular diagnostics business through the acquisition of myPOLS Biotec Kumar Jeetendra | February 1, 2022 Espoo, 1 February 2022 – Life Science Newswire – Medix Biochemica, a global leader in critical IVD raw materials, has acquired 100 percent of the shares of myPOLS Biotec GmbH (“myPOLS Biotec”). As a result of the acquisition, Medix Biochemica broadens its portfolio of molecular diagnostic raw materials for the in vitro diagnostics (“IVD”) industry, …
WAPG announces new partnerships with leading firms to secure free tax and legal advisory services for early-stage life sciences and healthcare companies Kumar Jeetendra | January 29, 2022 Today, We are Pioneer Group (WAPG) launches new nationwide partnerships with Leyton, the UK’s largest innovation funding consultancy, and leading UK law firm, Mills & Reeve. As a result of the innovative partnership, start-up ventures taking part in the WAPG business accelerator programme will gain free expert tax and legal advisory services. Free credits will …
